Johnson & Johnson to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
23 Juillet 2024 - 10:00PM
Business Wire
Johnson & Johnson (NYSE: JNJ) will participate in the Morgan
Stanley 22nd Annual Global Healthcare Conference on Wednesday,
September 4th, held at the New York Marriott Marquis, New York, NY.
Joaquin Duato, Chairman and Chief Executive Officer and John Reed,
Executive Vice President, Innovative Medicine, R&D will
represent the Company in a session scheduled at 10:45 am (Eastern
Time).
This live audio webcast will be available to investors and other
interested parties by accessing the Johnson & Johnson website
at www.investor.jnj.com.
The audio webcast replay will be available approximately 48-hrs
after the webcast.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240723451320/en/
Media contact: media-relations@its.jnj.com Investor
contact: investor-relations@its.jnj.com
Johnson and Johnson (NYSE:JNJ)
Graphique Historique de l'Action
De Sept 2024 à Oct 2024
Johnson and Johnson (NYSE:JNJ)
Graphique Historique de l'Action
De Oct 2023 à Oct 2024